Trial Profile
Effect of interventional treatment alone or combined with Entecavir in patients with hepatocellular carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2012
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B; Liver cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Dec 2013 to 1 Jan 2013 as reported by Chinese Clinical Trial Register.
- 14 Oct 2011 New trial record